Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	194.28	-4395.61	1493.67
Graham Fair Price	-63.51	< 0.005	0.02
PEG	inf	0.00	2.86
Price/Book	527.07	66.24	10.56
Price/Cash Flow	11.65	-68.14	-77.12
Prices/Earnings	11.65	-291.64	-330.10
Price/Sales	-11.65	1.77	2.00
Price/FCF	11.65	-68.14	-77.12
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.01	0.01
Operating Margin	< 0.005	< 0.005	< 0.005
ROA	-609.78	-0.02	< 0.005
ROE	< 0.005	-0.06	-609.78
ROIC	< 0.005	-0.02	-606.95
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.86	22.48	-96.17
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.05	0.03	-97.35
EPS QOQ	-1.15	0.00	inf
FCF QOQ	-6.76	0.03	-99.59
Revenue QOQ	0.45	-0.03	-93.82
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	35.70	35.70	< 0.005
Inventory Turnover	0.00	1089611669.00	100.00
Debt/Capitalization	0.33	0.33	0.81
Quick Ratio	0.93	6.02	547.06
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.05	< 0.005	-86.30
Cash	0.02	< 0.005	-56.34
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	2.78
Revenue	0.28	0.27	-2.78
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.26	1.26	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.92	17.57	35.98
Naive Interpretation	Member

06 - Financial Health · Weak

Rating